BRPI0620693A2 - método para suscitar uma resposta imune tanto sistêmica como de mucosa a mycobacteria viva atenuada ou antígenos micobacterianos em um hospedeiro - Google Patents

método para suscitar uma resposta imune tanto sistêmica como de mucosa a mycobacteria viva atenuada ou antígenos micobacterianos em um hospedeiro

Info

Publication number
BRPI0620693A2
BRPI0620693A2 BRPI0620693A BRPI0620693A BRPI0620693A2 BR PI0620693 A2 BRPI0620693 A2 BR PI0620693A2 BR PI0620693 A BRPI0620693 A BR PI0620693A BR PI0620693 A BRPI0620693 A BR PI0620693A BR PI0620693 A2 BRPI0620693 A2 BR PI0620693A2
Authority
BR
Brazil
Prior art keywords
eliciting
systemic
host
immune response
live attenuated
Prior art date
Application number
BRPI0620693A
Other languages
English (en)
Inventor
David Michael Hone
Jerald C Sadoff
Original Assignee
Aeras Global Tb Vaccine Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeras Global Tb Vaccine Found filed Critical Aeras Global Tb Vaccine Found
Publication of BRPI0620693A2 publication Critical patent/BRPI0620693A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6006—Cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0620693A 2005-12-15 2006-12-15 método para suscitar uma resposta imune tanto sistêmica como de mucosa a mycobacteria viva atenuada ou antígenos micobacterianos em um hospedeiro BRPI0620693A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75034805P 2005-12-15 2005-12-15
PCT/US2006/062143 WO2007079351A2 (en) 2005-12-15 2006-12-15 Novel prime-boost combinations of attenuated mycobacterium

Publications (1)

Publication Number Publication Date
BRPI0620693A2 true BRPI0620693A2 (pt) 2016-12-13

Family

ID=38228924

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0620693A BRPI0620693A2 (pt) 2005-12-15 2006-12-15 método para suscitar uma resposta imune tanto sistêmica como de mucosa a mycobacteria viva atenuada ou antígenos micobacterianos em um hospedeiro

Country Status (6)

Country Link
US (1) US20090304750A1 (pt)
EP (1) EP1962910A4 (pt)
CN (1) CN101432016A (pt)
BR (1) BRPI0620693A2 (pt)
WO (1) WO2007079351A2 (pt)
ZA (1) ZA200805395B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670609B2 (en) * 2007-11-27 2010-03-02 Aeras Global Tb Vaccine Foundation Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
AU2008339980A1 (en) * 2007-12-21 2009-07-02 Glaxosmithkline Biologicals S.A. Vaccines for malaria
CN102441162B (zh) * 2010-10-04 2018-07-24 免疫产品美国股份有限公司 结核病的治疗和预防
CN103214582B (zh) * 2013-04-02 2015-04-08 扬州大学 一种针对结核病具有免疫原性的融合蛋白及其应用
JP6554095B2 (ja) 2013-06-25 2019-07-31 アエラス グローバル ティービー ワクチン ファウンデーション 結核組成物及びそれを使用する方法
CN104151433A (zh) * 2014-08-11 2014-11-19 兰州大学 一种结核分枝杆菌融合蛋白及其制备方法和应用
CN109890411A (zh) 2016-06-16 2019-06-14 国际艾滋病疫苗行动组织公司 结核病组合物和治疗或预防结核病的方法
US11091775B2 (en) * 2016-06-22 2021-08-17 Oregon Health And Science University Recombinant cytomegalovirus vectors as vaccines for tuberculosis
EP3697806A4 (en) 2017-10-17 2021-10-27 International AIDS Vaccine Initiative, Inc. TUBERCULOSIS ANTIGEN CASSETTES
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190657B1 (en) * 1995-06-07 2001-02-20 Yale University Vectors for the diagnosis and treatment of solid tumors including melanoma
US7045336B1 (en) * 1995-09-06 2006-05-16 The United States Of America As Represented By The Secretary Of The Army Bacterial delivery system
US6210663B1 (en) * 1998-08-20 2001-04-03 The Wistar Institute Of Anatomy And Biology Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
US20040009936A1 (en) * 1999-05-03 2004-01-15 Tang De-Chu C. Vaccine and drug delivery by topical application of vectors and vector extracts
ES2370885T3 (es) * 2004-12-01 2011-12-23 Aeras Global Tuberculosis Vaccine Foundation Electroporación de mycobacterium y sobreexpresión de antígenos en micobacterias.

Also Published As

Publication number Publication date
US20090304750A1 (en) 2009-12-10
ZA200805395B (en) 2009-10-28
WO2007079351A2 (en) 2007-07-12
EP1962910A2 (en) 2008-09-03
WO2007079351A3 (en) 2008-08-14
EP1962910A4 (en) 2010-03-31
CN101432016A (zh) 2009-05-13

Similar Documents

Publication Publication Date Title
BRPI0620693A2 (pt) método para suscitar uma resposta imune tanto sistêmica como de mucosa a mycobacteria viva atenuada ou antígenos micobacterianos em um hospedeiro
CL2008003304A1 (es) Composicion inmunogenica para provocar una respuesta inmune anti-mycoplasma hyopneumoniae en un animal que comprende una cepa avirulenta viva de mycoplasma hyopneumoniae.
BRPI0810026A2 (pt) sistema de aquecimento para uma formação de subsuperfície, e, método para aquecer uma formação de subsuperfície
EP2235163A4 (en) RECOMBINANT BCG TUBERCULOSIS VACCINE FOR INDUCING IMMUNE REACTIONS AGAINST MYCOBACTERIUM TUBERCULOSIS
BRPI0919650A2 (pt) método e sistema para aquecer uma formação de subsuperfície
BRPI0908925A2 (pt) Sistema e método de geração de aerossol aquecido eletricamente
BRPI0716439A2 (pt) formulaÇÕes de flibanserina e mÉtodo para fabricaÇço das mesmas.
BRPI0923531A2 (pt) artigo que inclui uma informação de identificação para uso em um sistema para fumar eletricamente aquecido
FI20075654A0 (fi) Energiansiirtojärjestely ja -menetelmä
BRPI0918865A2 (pt) sistema e método para captação de energia solar e método de fabricação relacionado
BR112015009541A2 (pt) novos adjuvantes de mucosa e sistemas de aplicação
BRPI0919789A2 (pt) metodo para identificar peptídeos e proteínas alergênicas
BRPI0819338A2 (pt) Preparações, métodos e kits úteis para o tratamento de tosse
NL2001649A1 (nl) Non-bolt joint structure and method for producing non-bolt joint structure.
BRPI0905725A2 (pt) vacina, embalagem farmacêutica e processo para criar uma resposta imune em tecido de indivíduo
BRPI0811228A2 (pt) Composição liofilizada, e, métodos para produzir uma composição liofilizada e para produzir uma composição imunológica.
BRPI0812856A2 (pt) Composições de vacina de emulsão que compreendem antígeno e adjuvante na fase aquosa.
BR112012023512A2 (pt) dispositivo e método para produzir folhas isolantes pre-moldadas destinadas a serem inseridas nos sulcos do estator ou rotor
BRPI0822218A2 (pt) Transferases e oxidorredutases, ácidos nucleicos que as codificam e métodos para fazê-las e usá-las.
BRPI0919485A2 (pt) vacinas, antígenos, composições de plasmodium e métodos
WO2006071989A3 (en) Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
BRPI1005926A2 (pt) aparelho mictório para vaso sanitário, método motorizado, dispositivo mictório e método manual
BRPI0814250A2 (pt) Dispositivo, kit e método para captura e detecção de antígeno de tênia
BRPI1008208A2 (pt) "dispositivo de recuperação de calor, sistema termico e método para a recuperação de calor"
ZA200806340B (en) Mucosal immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO NO 018080036765 DE 13/06/2008.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: O DESPACHO 6.7 DA RPI NO 2129 DE 25/10/2011 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 - AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: O DESPACHO 11.6.1 DA RPI NO 2158 DE 15/05/2012 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 - AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]